Fundz

NodThera Announces Close of $55 Million Series B Financing

PRIVATEJun 03, 2020

Amount Raised

$55 Million

Round Type

Series B

United StatesBiotechnology

Description

NodThera, a clinical stage biotechnology company developing a new class of medicines that inhibit the NLRP3 inflammasome to treat diseases driven by chronic inflammation, today announced that it has secured $55 million (£44 million) in a Series B financing. NodThera’s lead candidate, NT-0167, is being evaluated in a Phase 1 clinical trial in healthy volunteers.

Quick answer

Nod Thera raised $55 Million in a Series B round, dated June 3, 2020. Nod Thera is based in United States.

How much did Nod Thera raise?
Nod Thera raised $55 Million in a Series B round on June 3, 2020.
What does Nod Thera do?
NodThera is developing a new class of potent and highly selective NLRP3 inflammasome inhibitors for the treatment of diseases driven by chronic inflammation.
Where is Nod Thera based and how big is it?
Nod Thera is based in United States. Fundz records about 23 employees.
Who are the decision-makers at Nod Thera?
Fundz holds 2 contacts at Nod Thera. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Nod Thera that raised within 45 days of this round, from Fundz verified event records.

  • Amunix Pharmaceuticals, Inc. raised an undisclosed amount on July 17, 2020.
  • GreenMark Biomedical Inc. raised an undisclosed amount on July 17, 2020.
  • SAB Biotherapeutics raised an undisclosed amount (Series B) on July 17, 2020.
  • Opal Biosciences, Inc. raised $1M (Seed) on July 16, 2020.
  • Virometix AG raised $5M (Series B) on July 16, 2020.
  • LeukoDx, Inc. raised $5M on July 16, 2020.

Who to call at Nod Thera, and when

A new round usually means Nod Thera is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Nod Thera raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nod Thera, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nod Thera. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nod Thera

Location

United States

About

NodThera is developing a new class of potent and highly selective NLRP3 inflammasome inhibitors for the treatment of diseases driven by chronic inflammation. We’re building a dynamic team of people across our offices in Cambridge, UK and Boston, MA; all united by our shared ambition, enthusiasm, and creativity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nod Thera raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Nod Thera's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Nod Thera raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.